Recombinant human AHSG (19-367 aa, derived from BC048198) fused with T7-His-TEV cleavage site Tag at N-terminal was expressed in E. coli.
1.0 mg/ml, sterile-filtered, in 20 mM pH 8.0 Tris-HCl Buffer, with proprietary formulation of NaCl, KCl, EDTA, Sucrose, DTT .
MASMTGGQQMGRGHHHHHHENLYFQGGEFAPHGPGLIYRQPNCDDPETEEAALVAIDYINQNLPWGYKHTLNQID EVKVWPQQPSGELFEIEIDTLETTCHVLDPTPVARCSVRQLKEHAVEGDCDFQLLKLDGKFSVVYAKCDSSPDSA EDVRKVCQDCPLLAPLNDTRVVHAAKAALAAFNAQNNGSNFQLEEISRAQLVPLPPSTYVEFTVSGTDCVAKEAT EAAKCNLLAEKQYGFCKATLSEKLGGAEVAVTCTVFQTQPVTSQPQPEGANEAVPTPVVDPDAPPSPPLGAPGLP PAGSPPDSHVLLAAPPGHQLHRAHYDLRHTFMGVVSLGSPSGEVSHPRKTRTVVQPSVGAAAGPVVPPCPGRIRH FKV
1. May be used for in vitro AHSG mediated cell differentiation / activation regulation study with this protein either as soluble factor or as coating matrix protein.2. May be used for mapping AHSG protein-protein interaction.3. May be used as specific substrate protein for kinase, and ubiquitin (Sumo pathway) related enzyme functional screening assays.4. Potential biomarker protein for early diagnosis of Rheumatoid Arthritis, Hypothyroidism et al.5. As antigen for specific antibody production.
Keep at -80 centigrade for long term storage. Product is stable at 4 centigrade for at least 7 days.